Jeffrey Houlton

University of Washington, Sarah Cannon

Papers

5

Total Citations

100

H-Index

5

About

Dr. Jeffrey Houlton is a head and neck surgical oncologist whose research centers on refining the role of transoral robotic surgery (TORS) in the management of oropharyngeal cancer, particularly HPV-positive disease. His major contributions include clarifying post-operative treatment pathways for patients with unknown primary cancers, demonstrating that TORS can effectively guide adjuvant therapy while minimizing overtreatment. His work on patterns of cervical node positivity and regional failure has helped define the oncologic safety and limitations of the robotic approach, with his most-cited paper (41 citations) establishing protocols for de-escalation of care. Dr. Houlton has also addressed critical clinical challenges, including the interpretation of surgical margins through multidisciplinary tumor board review—a key factor in reducing recurrence—and the efficacy of TORS for tonsillar carcinoma discovered after non-oncologic tonsillectomy. His studies on fistula rates and surgical options for locally advanced disease provide surgeons with evidence-based guidance for patient selection. Through these contributions, Dr. Houlton has helped shape the modern surgical management of oropharyngeal cancer, balancing oncologic control with functional preservation.

Research Focus

Key Achievements

5
H-Index
5
Papers
100
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Post-operative therapy following transoral robotic surgery for unknown primary cancers of the head and neck
41 citations · 2017
📈 Most Prolific Year: 2018 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: University of Washington, Sarah Cannon

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago